SEC Form 4 · accession 0001179110-15-011645
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Brannon Johnston
Officer — Chief Financial Officer
Period of report
Aug 3, 2015
Accepted (ET)
Aug 4, 2015 · 11:44 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 3, 2015 | M | 5,000 | $10.79 | A | 5,000 | D | |
| Common StockF1 | Aug 3, 2015 | S | 5,000 | $17.036 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $10.79 | Aug 3, 2015 | M | 5,000 | D | Jul 17, 2015 | Jul 17, 2024 | Common Stock | 5,000 | 95,000 | D |
Explanation of responses
- F1Weighted average price of shares sold
- F2The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 16, 2015.
- F3Exercisable as to 33,334 shares commencing on July 17, 2015, 33,333 shares commencing on July 17, 2016, and 33,333 shares commencing on July 17, 2017.